Policymakers across Europe and the United States are moving to classify many clinical AI tools as high-risk systems, ...
North America held a dominant market position, capturing more than a 40.3% share, holding USD 17.34 billion in revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback